New Zealand markets open in 5 hours 59 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
158.77+6.23 (+4.08%)
As of 10:01AM EST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
11,831,395
803,395
60,209
135,068
Cost of revenue
1,672,933
7,933
-
-
Gross profit
10,158,462
795,462
-
-
Operating expenses
Research development
2,102,339
1,370,339
496,309
454,082
Selling general and administrative
445,267
188,267
109,620
94,252
Total operating expenses
2,547,606
1,558,606
605,929
548,334
Operating income or loss
7,610,856
-763,144
-545,720
-413,266
Interest expense
15,886
9,886
6,612
-
Total other income/expenses net
-
3,802
-914
1,835
Income before tax
7,603,487
-744,513
-514,716
-384,408
Income tax expense
542,551
2,551
-695
326
Income from continuing operations
7,060,936
-747,064
-514,021
-384,734
Net income
7,060,936
-747,064
-514,021
-384,734
Net income available to common shareholders
7,060,936
-747,064
-514,021
-401,857
Basic EPS
-
-1.96
-1.55
-1.17
Diluted EPS
-
-1.96
-1.55
-1.17
Basic average shares
-
381,333
330,802
328,799
Diluted average shares
-
381,333
330,802
328,799
EBITDA
-
-703,376
-477,083
-388,404